"
Neuroblastoma in Saudi Children: A Single Center Experience (2006-2014)"
written by Zaid Al Naqib, Atif A. Ahmed, Musa Al Harbi, Fahad Al Manjomi, Zaheer Ullah Khan, Awatif Alanazi, Othman Mosleh, Walid Ballourah, Mohammed Rayis,
published by
Journal of Cancer Therapy,
Vol.6 No.10, 2015
has been cited by the following article(s):
|
[1]
|
Programmed Death Ligand-1 (PD-L1) Expression in Neuroblastoma: A Single Pediatric Oncology Center Experience
Innovative Journal of Pediatrics,
2025
DOI:10.5812/ijpediatr-159779
|
|
|
|
|
[2]
|
Dinutuximab-beta after autologous peripheral blood stem cell transplantation improved event-free survival of newly diagnosed children with high-risk neuroblastoma but overall survival remains unchanged: Saudi Arabia's multi-institutional experiences
European Journal of Oncology Pharmacy,
2024
DOI:10.1097/OP9.0000000000000058
|
|
|
|
|
[3]
|
Neuroblastoma in Sudan: experience of a single institute
Sudanese Journal of Paediatrics,
2020
DOI:10.24911/SJP.106-1570515379
|
|
|
|
|
[4]
|
Nanotechnological based miRNA intervention in the therapeutic management of neuroblastoma
Seminars in Cancer Biology,
2019
DOI:10.1016/j.semcancer.2019.09.017
|
|
|
|
|
[5]
|
Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors
Pediatric Hematology and Oncology,
2017
DOI:10.1080/08880018.2017.1330375
|
|
|
|